⌘K

Login Start Free

Home/Filings/4/0000899243-22-007424

4//SEC Filing

Kaplan Brett 4

Accession 0000899243-22-007424

CIK 0001738021other

View on SEC.gov Company Profile

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:45 PM ET

Size

5.3 KB

Accession

0000899243-22-007424

Insider Transaction Report

Form 4

Period: 2022-02-18

Compass Therapeutics, Inc.CMPX

Director

Transactions

Award
Stock Option (Right to Buy)
2022-02-18+30,000→ 30,000 total
Exercise: $2.40Exp: 2032-02-17→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]This option vests in substantially equal monthly installments over four years.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Compass Therapeutics, Inc.

CIK 0001738021

Entity typeother

Related Parties

1

filerCIK 0001778763

Filing Metadata

Form type: 4
Filed: Feb 22, 7:00 PM ET
Accepted: Feb 23, 5:45 PM ET
Size: 5.3 KB

View on SEC.gov